title: Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome.
authors.affiliation: Leiden University Medical Center, Leiden, The Netherlands. r.bokenkamp.kjc@lumc.nl <r.bokenkamp.kjc@lumc.nl>
authors.forename: Regina
authors.initials: R
authors.lastname: Bökenkamp
authors.forename: Arthur A
authors.initials: AA
authors.lastname: Wilde
authors.forename: Martin J
authors.initials: MJ
authors.lastname: Schalij
authors.forename: Nico A
authors.initials: NA
authors.lastname: Blom
mesh_terms: D050030:Andersen Syndrome / Q000150:complications / Q000188:drug therapy* / Q000235:genetics / Q000628:therapy; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D017147:Defibrillators, Implantable; D005260:Female; D005424:Flecainide / Q000627:therapeutic use*; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D009154:Mutation / Q000235:genetics; D024661:Potassium Channels, Inwardly Rectifying / Q000235:genetics; D012008:Recurrence; D035781:Siblings; D017180:Tachycardia, Ventricular / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D018879:Ventricular Premature Complexes / Q000209:etiology / Q000628:therapy
chemical_list: D000889:Anti-Arrhythmia Agents; C489457:KCNJ2 protein, human; D024661:Potassium Channels, Inwardly Rectifying; D005424:Flecainide